BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17681167)

  • 21. Cytochrome P4502C9 genotype in Southeast Anatolia and possible relation with some serum tumour markers and cytokines.
    Yilmaz N; Erbağci AB; Aynacioğlu AS
    Acta Biochim Pol; 2001; 48(3):775-82. PubMed ID: 11833786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?
    Langman MJ
    Pharmacoepidemiol Drug Saf; 2001; 10(1):13-9. PubMed ID: 11417061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is cytochrome P450 2C9 genotype associated with NSAID gastric ulceration?
    Martin JH; Begg EJ; Kennedy MA; Roberts R; Barclay ML
    Br J Clin Pharmacol; 2001 Jun; 51(6):627-30. PubMed ID: 11422024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of conserved Asp293 of cytochrome P450 2C9 in substrate recognition and catalytic activity.
    Flanagan JU; McLaughlin LA; Paine MJ; Sutcliffe MJ; Roberts GC; Wolf CR
    Biochem J; 2003 Mar; 370(Pt 3):921-6. PubMed ID: 12482324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piroxicam and gastrointestinal bleeding.
    Giercksky KE
    Am J Med; 1986 Nov; 81(5B):2-5. PubMed ID: 3491541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical aspects of upper gastrointestinal bleeding associated with the use of nonsteroidal antiinflammatory drugs.
    László A; Kelly JP; Kaufman DE; Sheehan JE; Rétsági G; Wiholm BE; Koff RS; Sundström A; Shapiro S
    Am J Gastroenterol; 1998 May; 93(5):721-5. PubMed ID: 9625116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding.
    Blot WJ; McLaughlin JK
    J Epidemiol Biostat; 2000; 5(2):137-42. PubMed ID: 10890286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonsteroidal anti-inflammatory drugs and gastrointestinal bleeding. A case-control study.
    Bartle WR; Gupta AK; Lazor J
    Arch Intern Med; 1986 Dec; 146(12):2365-7. PubMed ID: 3490836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonsteroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly.
    Beard K; Walker AM; Perera DR; Jick H
    Arch Intern Med; 1987 Sep; 147(9):1621-3. PubMed ID: 3498451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between upper gastrointestinal hemorrhage and drug use: a case control study.
    Chan TY; Critchley JA; Lau JT; Sung JJ; Chung SS; Anderson DC
    Int J Clin Pharmacol Ther; 1996 Jul; 34(7):304-8. PubMed ID: 8832307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptic ulcer disease and the nonsteroidal anti-inflammatory drugs.
    Peoples JB
    Am Surg; 1985 Jun; 51(6):358-62. PubMed ID: 3994179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease.
    Carson JL; Strom BL; Duff A; Gupta A; Das K
    Arch Intern Med; 1993 Jun; 153(11):1331-6. PubMed ID: 8507123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No association between non-steroidal anti-inflammatory drugs and acute appendicitis in a case-control study.
    Evans JM; Macgregor AM; Murray FE; Vaidya K; Morris AD; MacDonald TM
    Br J Surg; 1997 Mar; 84(3):372-4. PubMed ID: 9117311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9: effect on atypical kinetic metabolism profiles.
    Tracy TS; Hutzler JM; Haining RL; Rettie AE; Hummel MA; Dickmann LJ
    Drug Metab Dispos; 2002 Apr; 30(4):385-90. PubMed ID: 11901091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonsteroidal anti-inflammatory drug use in relation to major upper gastrointestinal bleeding.
    Kaufman DW; Kelly JP; Sheehan JE; Laszlo A; Wiholm BE; Alfredsson L; Koff RS; Shapiro S
    Clin Pharmacol Ther; 1993 Apr; 53(4):485-94. PubMed ID: 8477566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastrointestinal side-effects of NSAIDs in the community.
    Jones RH; Tait CL
    Br J Clin Pract; 1995; 49(2):67-70. PubMed ID: 7779646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy.
    Savage RL; Moller PW; Ballantyne CL; Wells JE
    Arthritis Rheum; 1993 Jan; 36(1):84-90. PubMed ID: 8424842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsteroidal antiinflammatory drugs and certain rare, serious adverse events: a cohort study.
    Jick H; Derby LE; García Rodríguez LA; Jick SS; Dean AD
    Pharmacotherapy; 1993; 13(3):212-7. PubMed ID: 8321735
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs.
    Langman MJ; Weil J; Wainwright P; Lawson DH; Rawlins MD; Logan RF; Murphy M; Vessey MP; Colin-Jones DG
    Lancet; 1994 Apr; 343(8905):1075-8. PubMed ID: 7909103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Observational survey of NSAID-related upper gastro-intestinal adverse events in Belgium.
    Belaiche J; Burette A; De Vos M; Louis E; Huybrechts M; Deltenre M;
    Acta Gastroenterol Belg; 2002; 65(2):65-73. PubMed ID: 12148440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.